CSIMarket
 


Vascular Biogenics Ltd   (VBLT)
Other Ticker:  
 
 

VBLT's Operating Income Growth by Quarter and Year

Vascular Biogenics Ltd 's Operating Income results by quarter and year




VBLT Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 32.85 0.00 0.00
III Quarter September 1.00 30.00 24.48 19.46
II Quarter June 0.86 0.00 0.00 0.00
I Quarter March 2.69 0.00 0.00 0.00
FY   4.55 62.85 24.48 19.46



VBLT Operating Income third quarter 2023 Y/Y Growth Comment
Vascular Biogenics Ltd reported drop in Operating Income in the third quarter 2023 by -96.65% to $ 1.00 millions, from the same quarter in 2022.
The fall in the third quarter 2023 Vascular Biogenics Ltd 's Operating Income compares unfavorably to the Company's average Operating Income increase of 14.49%.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 20 other companies have achieved higher Operating Income growth. While Vascular Biogenics Ltd ' s Operating Income meltdown of -96.65% ranks overall at the positon no. 899 in the third quarter 2023.

Explain Operating Income growth


VBLT Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September -96.65 % 22.55 % 25.8 % -4.89 %
II Quarter June - - - -
I Quarter March - - - -
FY   - 156.74 % 25.8 % -4.89 %

Financial Statements
Vascular Biogenics Ltd 's third quarter 2023 Operating Income $ 1.00 millions VBLT's Income Statement
Vascular Biogenics Ltd 's third quarter 2022 Operating Income $ 30.00 millions Quarterly VBLT's Income Statement
New: More VBLT's historic Operating Income Growth >>


VBLT Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 9.5 % - -
III Quarter September 16.74 % - - -
II Quarter June -68.03 % - - -
I Quarter March -91.81 % - - -
FY (Year on Year)   - 156.74 % 25.8 % -4.89 %




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #21
Healthcare Sector #58
Overall #899

Operating Income Y/Y Growth Statistics
High Average Low
25.83 % 14.49 % -4.89 %
(Dec 31 2020)   (Dec 31 2019)
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #21
Healthcare Sector #58
Overall #899
Operating Income Y/Y Growth Statistics
High Average Low
25.83 % 14.49 % -4.89 %
(Dec 31 2020)   (Dec 31 2019)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Vascular Biogenics Ltd 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
16.34 % -73.89 % -100 %
(Sep 30 2023)  


VBLT's III. Quarter Q/Q Operating Income Comment
Vascular Biogenics Ltd achieved in the III. Quarter 2023 above company average sequential Operating Income jump of 16.74%, to $ 1.00 millions, from $0.86 millions in the second quarter.
VBLT is undergoing a remarkable growth, with recording better then average growth, and additionally increasing speed, Evelyn White, Healthcare sector veteran said.

Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Operating Income quarter on quarter growth. While Vascular Biogenics Ltd 's Operating Income growth quarter on quarter, overall rank is 738.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #57
Overall #738
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #57
Overall #738
Operating Income Q/Q Growth Statistics
High Average Low
16.34 % -73.89 % -100 %
(Sep 30 2023)  


VBLT's III. Quarter Q/Q Operating Income Comment
Vascular Biogenics Ltd achieved in the III. Quarter 2023 above company average sequential Operating Income jump of 16.74%, to $ 1.00 millions, from $0.86 millions in the second quarter.
Vascular Biogenics Ltd is undergoing a remarkable growth, not just recording above average growth, but also improving rate.

Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Operating Income quarter on quarter growth. While Vascular Biogenics Ltd 's Operating Income growth quarter on quarter, overall rank is 738.


Vascular Biogenics Ltd 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Operating Income 12 Months Ending $ 37.41 $ 66.40 $ 0.00 $ 0.00 $ 30.00
Y / Y Operating Income Growth (TTM) - - - - 22.52 %
Year on Year Operating Income Growth Overall Ranking # 899 # 683 # 1236 # 1360 # 1640
Seqeuential Operating Income Change (TTM) -43.66 % - - - 22.52 %
Seq. Operating Income Growth (TTM) Overall Ranking # 899 # 675 # 1236 # 1360 # 1640




Cumulative Operating Income growth Comment


In the Healthcare sector 57 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 683 to 899.

Operating Income TTM Q/Q Growth Statistics
High Average Low
25.83 %
14.49 %
-4.89 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 58
Overall # 899

Operating Income TTM Y/Y Growth Statistics
High Average Low
25.83 %
14.49 %
-4.89 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 58
S&P 500 # 899
Cumulative Operating Income growth Comment


In the Healthcare sector 57 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 683 to 899.

Operating Income TTM Q/Q Growth Statistics
High Average Low
25.83 %
14.49 %
-4.89 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 58
Overall # 899

Operating Income TTM Y/Y Growth Statistics
High Average Low
25.83 %
14.49 %
-4.89 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 58
S&P 500 # 899




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
VBLT's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for VBLT's Competitors
Operating Income Growth for Vascular Biogenics Ltd 's Suppliers
Operating Income Growth for VBLT's Customers

You may also want to know
VBLT's Annual Growth Rates VBLT's Profitability Ratios VBLT's Asset Turnover Ratio VBLT's Dividend Growth
VBLT's Roe VBLT's Valuation Ratios VBLT's Financial Strength Ratios VBLT's Dividend Payout Ratio
VBLT's Roa VBLT's Inventory Turnover Ratio VBLT's Growth Rates VBLT's Dividend Comparisons



Companies with similar Operating Income jump for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Bio techne Corp-0.81%$ -0.808 millions
The Pennant Group Inc -1.16%$ -1.162 millions
Bio rad Laboratories Inc -1.99%$ -1.990 millions
Corcept Therapeutics Inc-2.37%$ -2.371 millions
Mettler toledo International Inc -3.07%$ -3.068 millions
Tenet Healthcare Corp-4.70%$ -4.698 millions
West Pharmaceutical Services Inc -4.78%$ -4.780 millions
Bruker Corporation-5.18%$ -5.179 millions
Henry Schein Inc-5.21%$ -5.213 millions
Hologic Inc-5.96%$ -5.962 millions
Sonida Senior Living Inc -6.27%$ -6.269 millions
Abbott Laboratories-6.95%$ -6.949 millions
Gilead Sciences Inc -7.54%$ -7.543 millions
Vertex Pharmaceuticals Inc-7.86%$ -7.864 millions
Bristol myers Squibb Company-9.18%$ -9.183 millions
Regeneron Pharmaceuticals Inc -9.21%$ -9.210 millions
National Research Corporation-10.39%$ -10.388 millions
Quest Diagnostics Inc-12.76%$ -12.755 millions
Bausch and Lomb Corp-13.04%$ -13.043 millions
Carlisle Companies Incorporated-13.87%$ -13.871 millions
Pediatrix Medical Group Inc -15.01%$ -15.015 millions
Community Health Systems Inc -15.20%$ -15.196 millions
Teva Pharmaceutical Industries Limited-15.27%$ -15.274 millions
Zynex inc -16.36%$ -16.362 millions
Entera Bio Ltd -16.72%$ -16.719 millions
Pacira Biosciences inc -16.76%$ -16.760 millions
Viatris Inc -19.35%$ -19.354 millions
Royalty Pharma Plc-21.21%$ -21.210 millions
Luna Innovations Inc-22.06%$ -22.057 millions
Avantor Inc -23.79%$ -23.785 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com